Andong Cheng1,2,#, Yiding Chen1,#, Hao Li1, Feixiang Yang1, Junlan Jiang3, Sheng Tai1, Weiwei Chen4, Yu Guan1, Shuiping Yin1,*, Jialin Meng1,2,*
Oncology Research, Vol.34, No.2, 2026, DOI:10.32604/or.2025.066478
- 19 January 2026
Abstract Background: In clinical practice, approximately 80% of prostate cancer (PC) cases are localized and can achieve favorable outcomes with appropriate treatment. Conversely, some remaining cases exhibit an aggressive phenotype or develop resistance to therapeutic interventions, leading to tumor metastasis and a poorer prognosis. When PC metastasizes to distant sites, the bone remains the predominant location, and brain metastases are regarded as exceedingly rare. Case Description: The current study focused on a rare clinical PC case that presented multiple brain metastases after prostate surgery. The patient was initially diagnosed with PC through prostate biopsy and subsequently underwent More >